| FGF/FGFR signaling in health and disease Y Xie, N Su, J Yang, Q Tan, S Huang, M Jin, Z Ni, B Zhang, D Zhang, ... Signal transduction and targeted therapy 5 (1), 181, 2020 | 474 | 2020 |
| Th9 cells promote antitumor immune responses in vivo Y Lu, S Hong, H Li, J Park, B Hong, L Wang, Y Zheng, Z Liu, J Xu, J He, ... The Journal of clinical investigation 122 (11), 4160-4171, 2012 | 410 | 2012 |
| Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug–induced apoptosis Y Zheng, Z Cai, S Wang, X Zhang, J Qian, S Hong, H Li, M Wang, J Yang, ... Blood, The Journal of the American Society of Hematology 114 (17), 3625-3628, 2009 | 328 | 2009 |
| Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells H Li, S Hong, J Qian, Y Zheng, J Yang, Q Yi Blood, The Journal of the American Society of Hematology 116 (2), 210-217, 2010 | 245 | 2010 |
| PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma Y Zheng, J Yang, J Qian, P Qiu, S Hanabuchi, Y Lu, Z Wang, Z Liu, H Li, ... Leukemia 27 (3), 702-710, 2013 | 154 | 2013 |
| A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis L Yin, X Du, C Li, X Xu, Z Chen, N Su, L Zhao, H Qi, F Li, J Xue, J Yang, ... Bone 42 (4), 631-643, 2008 | 150 | 2008 |
| Human C-reactive protein binds activating Fcγ receptors and protects myeloma tumor cells from apoptosis J Yang, M Wezeman, X Zhang, P Lin, M Wang, J Qian, B Wan, LW Kwak, ... Cancer cell 12 (3), 252-265, 2007 | 143 | 2007 |
| Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation Z Liu, J Xu, J He, H Liu, P Lin, X Wan, NM Navone, Q Tong, LW Kwak, ... Oncotarget 6 (33), 34329, 2015 | 141 | 2015 |
| Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma J Qian, J Xie, S Hong, J Yang, L Zhang, X Han, M Wang, F Zhan, ... Blood, The Journal of the American Society of Hematology 110 (5), 1587-1594, 2007 | 140 | 2007 |
| Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications CC Bjorklund, V Baladandayuthapani, HY Lin, RJ Jones, I Kuiatse, ... Leukemia 28 (2), 373-383, 2014 | 135 | 2014 |
| Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells L Zhang, J Yang, J Qian, H Li, JE Romaguera, LW Kwak, M Wang, Q Yi Blood, The Journal of the American Society of Hematology 120 (18), 3783-3792, 2012 | 127 | 2012 |
| Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma S Wang, J Yang, J Qian, M Wezeman, LW Kwak, Q Yi Blood 107 (6), 2432-2439, 2006 | 122 | 2006 |
| Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells J Xie, J Qian, J Yang, S Wang, ME Freeman III, Q Yi Experimental hematology 33 (5), 564-572, 2005 | 117 | 2005 |
| Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing … S Wang, S Hong, J Yang, J Qian, X Zhang, E Shpall, LW Kwak, Q Yi Blood 108 (13), 4071-4077, 2006 | 112 | 2006 |
| Targeting β2-microglobulin for induction of tumor apoptosis in human hematological malignancies J Yang, J Qian, M Wezeman, S Wang, P Lin, M Wang, S Yaccoby, ... Cancer cell 10 (4), 295-307, 2006 | 108 | 2006 |
| Bone function, dysfunction and its role in diseases including critical illness N Su, J Yang, Y Xie, X Du, H Chen, H Zhou, L Chen International journal of biological sciences 15 (4), 776, 2019 | 105 | 2019 |
| A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance Z Liu, J Xu, J He, Y Zheng, H Li, Y Lu, J Qian, P Lin, DM Weber, J Yang, ... Blood, The Journal of the American Society of Hematology 124 (13), 2061-2071, 2014 | 105 | 2014 |
| Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo M Wang, XH Han, L Zhang, J Yang, JF Qian, YK Shi, LW Kwak, ... Leukemia 22 (1), 179-185, 2008 | 105 | 2008 |
| Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis N Su, Q Sun, C Li, X Lu, H Qi, S Chen, J Yang, X Du, L Zhao, Q He, M Jin, ... Human molecular genetics 19 (7), 1199-1210, 2010 | 98 | 2010 |
| Tight junction protein 1 modulates proteasome capacity and proteasome inhibitor sensitivity in multiple myeloma via EGFR/JAK1/STAT3 signaling XD Zhang, V Baladandayuthapani, H Lin, G Mulligan, B Li, DLW Esseltine, ... Cancer cell 29 (5), 639-652, 2016 | 97 | 2016 |
